BTA biota holdings limited

glaxo ups relenza output

  1. 3,045 Posts.
    Great to see a firm number, 60m per annum. Current orders may be supplied from their current stock of 6m units.


    "Glaxo said it was set to produce 5 million treatment packs of Relenza a month within the next 12 to 14 weeks, equivalent to an annual run rate of 50-60 million."

    "The British company said it currently had 6 million packs of existing Relenza stock and was prioritising orders to governments, a number of which are supplementing their stockpiles of antivirals because of the imminent threat of a pandemic."

    http://uk.reuters.com/article/topNews/idUKTRE5405DB20090501

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.